Molecular Weight(MW): 364.42
Bumetanide (Bumex) is a loop diuretic of the sulfamyl category to treat heart failure.
Purity & Quality Control
|Description||Bumetanide (Bumex) is a loop diuretic of the sulfamyl category to treat heart failure.|
|In vitro||DMSO||73 mg/mL (200.31 mM)|
|Ethanol||36 mg/mL (98.78 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT02947880||Not yet recruiting||Autistic Disorder||University Hospital, Limoges||December 2016||Phase 2|
|NCT02593526||Recruiting||Chronic Kidney Insufficiency||University of New Mexico|Dialysis Clinic, Inc.||August 2016||--|
|NCT02546583||Recruiting||Heart Failure||Yale University||August 2015||--|
|NCT02582476||Recruiting||Hypokalemic Periodic Paralysis||University College, London||January 2015||Phase 2|
|NCT01457053||Terminated||Acute Decompensated Heart Failure||University of Cincinnati||November 2011||--|
|NCT01434225||Completed||Neonatal Seizures||Great Ormond Street Hospital for Children NHS Foundation Trust|Only For Children Pharmaceuticals|Cork University Hospital|UMC Utrecht|Helsinki University Central Hospital|Hôpital Necker-Enfants Malades|The Leeds Teaching Hospitals NHS Trust|Karolinska University Hospital|University College London Hospitals|Uppsala University Hospital|Erasmus Medical Center||August 2011||Phase 1|Phase 2|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.